Literature DB >> 12671176

Non-O157 verotoxin-producing Escherichia coli: a problem, paradox, and paradigm.

Karl A Bettelheim1.   

Abstract

The problems associated with identification and characterization of non-O157 verotoxin-producing Escherichia coli (VTEC) are discussed. The paradox of VTEC is that most reports of human illnesses are associated with serotypes such as O157:H7, O111:H- (nonmotile), O26:H11, and O113:H21, which are rarely found in domestic animals. However, those VTEC serotypes commonly found in domestic animals, especially ruminants, rarely cause human illnesses. When they cause human illnesses, the symptoms are similar to those caused by the serotypes E. coli O157:H7, O111:H-, O26:H11, and O113:H21. The impact of VTEC on human and animal health is also addressed. The VTEC and their toxicity are considered as a paradigm for emerging pathogens. The question on how such pathogens could arise from a basic commensal population is also addressed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12671176     DOI: 10.1177/153537020322800402

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  14 in total

1.  Haemolytic uraemic syndrome associated with interfamilial spread of E. coli O26:H11.

Authors:  G Sayers; T McCarthy; M O'Connell; M O'Leary; D O'Brien; M Cafferkey; E McNamara
Journal:  Epidemiol Infect       Date:  2005-12-22       Impact factor: 2.451

2.  Longitudinal study of Shiga toxin-producing Escherichia coli shedding in sheep feces: persistence of specific clones in sheep flocks.

Authors:  Sergio Sánchez; Remigio Martínez; Alfredo García; Jorge Blanco; Jesús E Blanco; Miguel Blanco; Ghizlane Dahbi; Cecilia López; Azucena Mora; Joaquín Rey; Juan M Alonso
Journal:  Appl Environ Microbiol       Date:  2009-01-23       Impact factor: 4.792

3.  Molecular serotyping of Escherichia coli O26:H11.

Authors:  Lisa M Durso; James L Bono; James E Keen
Journal:  Appl Environ Microbiol       Date:  2005-08       Impact factor: 4.792

4.  Emerging Shiga toxin-producing Escherichia coli serotypes in Europe: O100:H- and O127:H40.

Authors:  Dorothea Orth; Katharina Grif; Ian Fisher; Angelika Fruth; Helmut Tschäpe; Flemming Scheutz; Manfred P Dierich; Reinhard Würzner
Journal:  Curr Microbiol       Date:  2006-10-19       Impact factor: 2.188

5.  Isolation of Escherichia coli from piglets in South Korea with diarrhea and characteristics of the virulence genes.

Authors:  Yeong Ju Kim; Ji Hee Kim; Jin Hur; John Hwa Lee
Journal:  Can J Vet Res       Date:  2010-01       Impact factor: 1.310

6.  Importance of environmental transmission in cases of EHEC O157 causing hemolytic uremic syndrome.

Authors:  K Grif; D Orth; I Lederer; C Berghold; S Roedl; C J Mache; M P Dierich; R Würzner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-04       Impact factor: 3.267

7.  Distribution of putative adhesins in different seropathotypes of Shiga toxin-producing Escherichia coli.

Authors:  Claudia Toma; Estela Martínez Espinosa; Tianyan Song; Elizabeth Miliwebsky; Isabel Chinen; Sunao Iyoda; Masaaki Iwanaga; Marta Rivas
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

8.  Prevalence and characterization of shiga toxin-producing Escherichia coli in swine feces recovered in the National Animal Health Monitoring System's Swine 2000 study.

Authors:  Pina M Fratamico; Lori K Bagi; Eric J Bush; Barbara T Solow
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

9.  Pathogenic potential to humans of bovine Escherichia coli O26, Scotland.

Authors:  Margo E Chase-Topping; Tracy Rosser; Lesley J Allison; Emily Courcier; Judith Evans; Iain J McKendrick; Michael C Pearce; Ian Handel; Alfredo Caprioli; Helge Karch; Mary F Hanson; Kevin G J Pollock; Mary E Locking; Mark E J Woolhouse; Louise Matthews; J Chris Low; David L Gally
Journal:  Emerg Infect Dis       Date:  2012-03       Impact factor: 6.883

10.  Enterohemorrhagic Escherichia coll excretion by child and her cat.

Authors:  Ulrich Busch; Stefan Hörmansdorfer; Stephan Schranner; Ingrid Huber; Karl-Heinz Bogner; Andreas Sing
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.